Assembly Biosciences, Inc.: 10-K filed 2012-03-14
What Assembly Biosciences, Inc. reported in its annual report filed 2012-03-14 (fiscal FY 2011): 23 published measures, 72 facts as tagged in accession 0001144204-12-014863.
This filing
- Form
- 10-K (annual report)
- Filed
- 2012-03-14
- Fiscal period
- fiscal FY 2011
- Accession
- 0001144204-12-014863 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Assembly Biosciences, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 37,045,781 | USD | |
| At 2010-12-31 | 14,616,601 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 2,513,074 | USD | |
| At 2010-12-31 | 2,990,485 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 34,532,707 | USD | |
| At 2010-12-31 | 11,626,116 | USD | |
| At 2009-12-31 | -13,362,648 | USD | |
| At 2008-12-31 | -9,457,050 | USD | |
| At 2007-12-31 | -4,382,043 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 36,975,434 | USD | |
| At 2010-12-31 | 14,571,055 | USD | |
| At 2009-12-31 | 81,288 | USD | |
| At 2008-12-31 | 15,851 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -34,344,730 | USD | 365 |
| 2005-10-07 to 2011-12-31 | -67,529,084 | USD | 2277 |
| 2010-01-01 to 2010-12-31 | -15,290,625 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -4,539,405 | USD | 365 |
| 2008-01-01 to 2008-12-31 | -8,786,430 | USD | 366 |
| 2007-01-01 to 2007-12-31 | -4,567,894 | USD | 365 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -25,068,832 | USD | 365 |
| 2005-10-07 to 2011-12-31 | -40,438,299 | USD | 2277 |
| 2010-01-01 to 2010-12-31 | -5,214,427 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -3,483,919 | USD | 365 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 11,964 | USD | 365 |
| 2005-10-07 to 2011-12-31 | 39,224 | USD | 2277 |
| 2009-01-01 to 2009-12-31 | 2,573 | USD | 365 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 47,485,175 | USD | 365 |
| 2005-10-07 to 2011-12-31 | 77,452,957 | USD | 2277 |
| 2010-01-01 to 2010-12-31 | 19,704,194 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 3,551,929 | USD | 365 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 8,218 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 2,982,949 | USD | 365 |
| 2005-10-07 to 2011-12-31 | 5,940,271 | USD | 2277 |
| 2010-01-01 to 2010-12-31 | 2,356,087 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 123,758 | USD | 365 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -34,002,073 | USD | 365 |
| 2005-10-07 to 2011-12-31 | -53,776,311 | USD | 2277 |
| 2010-01-01 to 2010-12-31 | -4,766,256 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -3,340,230 | USD | 365 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 37,037,563 | USD | |
| At 2010-12-31 | 14,589,970 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 116,664 | USD | 365 |
| 2005-10-07 to 2011-12-31 | 4,983,572 | USD | 2277 |
| 2010-01-01 to 2010-12-31 | 2,043,676 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 1,120,811 | USD | 365 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 2,513,074 | USD | |
| At 2010-12-31 | 1,719,812 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 2,342,074 | USD | |
| At 2010-12-31 | 312,896 | USD |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 25,277,682 | USD | 365 |
| 2005-10-07 to 2011-12-31 | 39,529,243 | USD | 2277 |
| 2010-01-01 to 2010-12-31 | 1,850,666 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 2,942,992 | USD | 365 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 12,406,406 | shares | |
| At 2010-12-31 | 6,746,365 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 102,049,385 | USD | |
| At 2010-12-31 | 44,803,724 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 28,432 | USD | |
| At 2010-12-31 | 27,260 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-12-31 | 171,000 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 8,724,391 | USD | 365 |
| 2005-10-07 to 2011-12-31 | 14,245,068 | USD | 2277 |
| 2010-01-01 to 2010-12-31 | 2,915,590 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 397,238 | USD | 365 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | 3,746 | USD | 365 |
| 2005-10-07 to 2011-12-31 | 31,006 | USD | 2277 |
| 2010-01-01 to 2010-12-31 | 12,525 | USD | 365 |
| 2009-01-01 to 2009-12-31 | 7,511 | USD | 365 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-01-01 to 2011-12-31 | -342,657 | USD | 365 |
| 2005-10-07 to 2011-12-31 | -13,754,773 | USD | 2277 |
| 2010-01-01 to 2010-12-31 | -10,524,369 | USD | 365 |
| 2009-01-01 to 2009-12-31 | -1,199,175 | USD | 365 |
Inspect the source
- Entity
- Assembly Biosciences, Inc. / CIK 0001426800
- Captured
- 2026-09-20T08:03:55.156Z
- SEC response SHA-256
f87ee3d44f43bd73d30c280e8d97b2de4bcc4d8a35b03fbebb0e715c83069335
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001426800.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))